InvestorsHub Logo
Followers 4053
Posts 151256
Boards Moderated 4
Alias Born 08/05/2009

Re: BuckeyeStocks post# 229

Friday, 12/08/2023 3:00:04 PM

Friday, December 08, 2023 3:00:04 PM

Post# of 259
Casgevy, developed by partners Vertex Pharmaceuticals (VRTX) and CRISPR Therapeutics (CRSP), and bluebird bio's (BLUE.) Lyfgenia were approved for people aged 12 years and older.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-approves-two-gene-therapies-sickle-cell-disease-2023-12-08/

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News